Background: Loss of DNA mismatch repair (MMR) increases mutagenesis and tumorigenesis. mutS homolog 2 (MSH2), a central component of the MMR pathway, is essential for correcting base-base mismatches and insertion/deletion loops during DNA replication. To investigate how Msh2 deficiency cooperates with oxidative stress to drive mutagenesis and tumorigenesis, we employed an rpsL reporter gene assay using normal tissues before tumor development following treatment with an oxidizing agent.
Results: The background mutation frequency in the small intestines of Msh2-/- mice was over 20-fold higher than that of wild-type mice. In addition to G > A base substitutions, frequent 1-bp deletions in adenine mononucleotide repeats ((A)n) in the rpsL gene were observed. Potassium bromate treatment further increased the mutation frequency, particularly insertion-deletion mutations (indel), in the normal small intestinal epithelium of Msh2-/- mice before tumor development. Mutation signature analysis from next-generation sequencing data revealed that signatures associated with MMR deficiency (SBS15, SBS44, and ID2) and clock-like processes (SBS1 and SBS5) were consistently detected across all Msh2-/- tumors, similar to those observed in human MMR-deficient cancers. ID2, which involves 1-base deletions occurring in (A/T)n tracts of six bases or longer, supports the findings of the rpsL assay. Microsatellite instability (MSI) analysis showed that indel mutations at (A)n loci detected using the rpsL assay reflect genome-wide MSI. Msh2-/- tumors frequently harbored driver mutations, such as frameshift mutations in short tandem repeats within Apc and G > A substitutions in Ctnnb1, both of which activate the Wnt signaling pathway. Oxidative stress further accelerated these mutational processes.
Conclusion: Oxidative stress promotes repeat-associated mutagenesis, which manifests as MSI and base substitutions in MMR-deficient intestinal tissues, thereby enhancing the mutator phenotype and increasing the overall mutation burden. This process can be sensitively captured using our rpsL assay, which serves as a functional indicator of MMR deficiency and replication instability in normal tissues before tumor formation. This increases the likelihood of driver mutations in oncogenes and tumor suppressor genes, ultimately accelerating early tumorigenesis. This study demonstrated that MSH2 is essential for maintaining genome stability under oxidative conditions and functions as a key suppressor of oxidative stress-induced tumorigenesis.
{"title":"Oxidative stress accelerates repeat sequence instability and base substitutions promoting gastrointestinal driver mutations in MSH2 deficient mice.","authors":"Mizuki Ohno, Noriko Takano, Kyoko Hidaka, Fumiko Sasaki, Yasunobu Aoki, Takehiko Nohmi, Teruhisa Tsuzuki","doi":"10.1186/s41021-025-00342-y","DOIUrl":"10.1186/s41021-025-00342-y","url":null,"abstract":"<p><strong>Background: </strong>Loss of DNA mismatch repair (MMR) increases mutagenesis and tumorigenesis. mutS homolog 2 (MSH2), a central component of the MMR pathway, is essential for correcting base-base mismatches and insertion/deletion loops during DNA replication. To investigate how Msh2 deficiency cooperates with oxidative stress to drive mutagenesis and tumorigenesis, we employed an rpsL reporter gene assay using normal tissues before tumor development following treatment with an oxidizing agent.</p><p><strong>Results: </strong>The background mutation frequency in the small intestines of Msh2<sup>-/-</sup> mice was over 20-fold higher than that of wild-type mice. In addition to G > A base substitutions, frequent 1-bp deletions in adenine mononucleotide repeats ((A)n) in the rpsL gene were observed. Potassium bromate treatment further increased the mutation frequency, particularly insertion-deletion mutations (indel), in the normal small intestinal epithelium of Msh2<sup>-/-</sup> mice before tumor development. Mutation signature analysis from next-generation sequencing data revealed that signatures associated with MMR deficiency (SBS15, SBS44, and ID2) and clock-like processes (SBS1 and SBS5) were consistently detected across all Msh2<sup>-/-</sup> tumors, similar to those observed in human MMR-deficient cancers. ID2, which involves 1-base deletions occurring in (A/T)<sub>n</sub> tracts of six bases or longer, supports the findings of the rpsL assay. Microsatellite instability (MSI) analysis showed that indel mutations at (A)n loci detected using the rpsL assay reflect genome-wide MSI. Msh2<sup>-/-</sup> tumors frequently harbored driver mutations, such as frameshift mutations in short tandem repeats within Apc and G > A substitutions in Ctnnb1, both of which activate the Wnt signaling pathway. Oxidative stress further accelerated these mutational processes.</p><p><strong>Conclusion: </strong>Oxidative stress promotes repeat-associated mutagenesis, which manifests as MSI and base substitutions in MMR-deficient intestinal tissues, thereby enhancing the mutator phenotype and increasing the overall mutation burden. This process can be sensitively captured using our rpsL assay, which serves as a functional indicator of MMR deficiency and replication instability in normal tissues before tumor formation. This increases the likelihood of driver mutations in oncogenes and tumor suppressor genes, ultimately accelerating early tumorigenesis. This study demonstrated that MSH2 is essential for maintaining genome stability under oxidative conditions and functions as a key suppressor of oxidative stress-induced tumorigenesis.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"19"},"PeriodicalIF":1.9,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12548293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145354588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-16DOI: 10.1186/s41021-025-00340-0
Ruriko Fukushima, Tetsuya Suzuki, Hiroyuki Kamiya
Background: 8-Oxo-7,8-dihydroguanine (8-hydroxyguanine, GO) is a major damaged base caused by oxidation. Misincorporation of dATP opposite GO by DNA polymerases leads to a G:C→T:A transversion at the damaged site via GO:A intermediate formation. The GO:A pair is also formed by 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate incorporation opposite A. The GO:C and GO:A pairs are both repaired through the base excision repair (BER) pathway to suppress the G:C→T:A mutations. GO:C also induces action-at-a-distance mutations around the damaged base. These untargeted mutations seem to be induced through the excision of GO from GO:C by DNA glycosylases, such as OGG1 and NEIL1, in the BER pathway. The adenine base of GO:A is excised by a specific adenine DNA glycosylase, MUTYH, and this excision potentially induces action-at-a-distance mutations.
Results: In this study, plasmid DNA bearing a GO:A pair was introduced into human U2OS cells to investigate the untargeted mutations by the GO:A pair. The GO:A pair induced action-at-a-distance mutations at C bases in 5'-TpC-3' of the GO-strand, in contrast to those by GO:C, which elicit mutations at G bases of 5'-GpA-3'. Furthermore, the untargeted mutations were suppressed by the MUTYH knockdown.
Conclusion: The GO:A pair induced the action-at-a-distance mutations through base excision by the MUTYH glycosylase.
{"title":"Action-at-a-distance mutations by 8-oxo-7,8-dihydroguanine: adenine pair triggered by MUTYH.","authors":"Ruriko Fukushima, Tetsuya Suzuki, Hiroyuki Kamiya","doi":"10.1186/s41021-025-00340-0","DOIUrl":"10.1186/s41021-025-00340-0","url":null,"abstract":"<p><strong>Background: </strong>8-Oxo-7,8-dihydroguanine (8-hydroxyguanine, G<sup>O</sup>) is a major damaged base caused by oxidation. Misincorporation of dATP opposite G<sup>O</sup> by DNA polymerases leads to a G:C→T:A transversion at the damaged site via G<sup>O</sup>:A intermediate formation. The G<sup>O</sup>:A pair is also formed by 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate incorporation opposite A. The G<sup>O</sup>:C and G<sup>O</sup>:A pairs are both repaired through the base excision repair (BER) pathway to suppress the G:C→T:A mutations. G<sup>O</sup>:C also induces action-at-a-distance mutations around the damaged base. These untargeted mutations seem to be induced through the excision of G<sup>O</sup> from G<sup>O</sup>:C by DNA glycosylases, such as OGG1 and NEIL1, in the BER pathway. The adenine base of G<sup>O</sup>:A is excised by a specific adenine DNA glycosylase, MUTYH, and this excision potentially induces action-at-a-distance mutations.</p><p><strong>Results: </strong>In this study, plasmid DNA bearing a G<sup>O</sup>:A pair was introduced into human U2OS cells to investigate the untargeted mutations by the G<sup>O</sup>:A pair. The G<sup>O</sup>:A pair induced action-at-a-distance mutations at C bases in 5'-TpC-3' of the G<sup>O</sup>-strand, in contrast to those by G<sup>O</sup>:C, which elicit mutations at G bases of 5'-GpA-3'. Furthermore, the untargeted mutations were suppressed by the MUTYH knockdown.</p><p><strong>Conclusion: </strong>The G<sup>O</sup>:A pair induced the action-at-a-distance mutations through base excision by the MUTYH glycosylase.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"18"},"PeriodicalIF":1.9,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12529804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145307811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Prostate cancer is still the most common malignancy affecting men worldwide, with causes ranging from genetics to environmental and lifestyle factors. This review narrows its attention to investigate smoking as a risk factor for the start and progression of prostate cancer. While age, ethnic differences, family history, and genetic abnormalities such as BRCA1 and BRCA2 remain important, smoking-particularly long-term and heavy use-emerges as a modifiable risk factor that needs deeper consideration. Though this review attempts to offer a worldwide perspective on smoking and prostate cancer risk, we also include a focus on new research from India, given the country's particular regional patterns and growing evidence.
Methods: A systematic review of PubMed, Scopus, and Web of Science was undertaken using "smoking" and "prostate cancer." The criteria for selecting articles were relevancy, developing research, and accessibility. The exclusion criteria eliminated non-human research and associated issues. This study examined worldwide patterns, however primarily focused on tobacco use and prostate cancer in India according to recent findings. Regional research emphasised smoking and prostate cancer risk patterns and mechanisms.
Results: Tobacco use is still a substantial risk factor for several malignancies, including prostate cancer. Globally, smoking has been associated with an increased risk of getting prostate cancer, with research indicating that smokers had a greater prevalence of aggressive illness. Tobacco usage is very common in India owing to a variety of cultural, societal, and economic variables; hence it is a key focus of this research. The effect of tobacco in prostate cancer risk in India is still being studied, and the data shows that smoking in the Indian population may worsen the development and progression of prostate cancer, similar to worldwide patterns but with regional differences.
Conclusions: Understanding how smoking affects prostate cancer may improve prevention and early diagnosis, which has public health consequences. These methods may involve targeted screening or lifestyle changes. This review emphasis smoking as a key prostate cancer risk factor, focusing on new Indian findings. More research is required to assess smoking's full impact on prostate cancer risk, particularly in different populations and locations.
背景:前列腺癌仍然是世界范围内影响男性最常见的恶性肿瘤,其病因从遗传到环境和生活方式因素不等。这篇综述将研究范围缩小到吸烟作为前列腺癌发病和发展的危险因素。虽然年龄、种族差异、家族史和基因异常(如BRCA1和BRCA2)仍然很重要,但吸烟——尤其是长期和大量吸烟——成为一个需要深入考虑的可改变的风险因素。尽管这篇综述试图提供吸烟和前列腺癌风险的全球视角,但鉴于印度的特殊区域模式和越来越多的证据,我们也将重点放在了印度的新研究上。方法:使用“吸烟”和“前列腺癌”对PubMed、Scopus和Web of Science进行系统综述。选择文章的标准是相关性、发展研究和可及性。排除标准排除了非人类研究和相关问题。这项研究调查了世界范围内的模式,但根据最近的发现,主要关注的是印度的烟草使用和前列腺癌。区域研究强调吸烟和前列腺癌的风险模式和机制。结果:吸烟仍然是包括前列腺癌在内的几种恶性肿瘤的重要危险因素。在全球范围内,吸烟与患前列腺癌的风险增加有关,研究表明,吸烟者患侵袭性疾病的几率更高。由于各种文化、社会和经济变量,烟草使用在印度非常普遍;因此,这是本研究的重点。烟草对印度前列腺癌风险的影响仍在研究中,数据显示,印度人口中吸烟可能会加剧前列腺癌的发展和进展,与世界范围内的模式相似,但存在地区差异。结论:了解吸烟对前列腺癌的影响可能有助于预防和早期诊断,这对公众健康有重要影响。这些方法可能包括有针对性的筛查或生活方式的改变。这篇综述强调吸烟是一个关键的前列腺癌风险因素,重点是印度的新发现。需要更多的研究来评估吸烟对前列腺癌风险的全面影响,特别是在不同的人群和地区。
{"title":"Smoking and the risk of prostate cancer: a review of risk and disease progression.","authors":"Ishvaria Sundaresan, Nallasivam Palanisamy, Radha Saraswathy","doi":"10.1186/s41021-025-00338-8","DOIUrl":"10.1186/s41021-025-00338-8","url":null,"abstract":"<p><strong>Background: </strong>Prostate cancer is still the most common malignancy affecting men worldwide, with causes ranging from genetics to environmental and lifestyle factors. This review narrows its attention to investigate smoking as a risk factor for the start and progression of prostate cancer. While age, ethnic differences, family history, and genetic abnormalities such as BRCA1 and BRCA2 remain important, smoking-particularly long-term and heavy use-emerges as a modifiable risk factor that needs deeper consideration. Though this review attempts to offer a worldwide perspective on smoking and prostate cancer risk, we also include a focus on new research from India, given the country's particular regional patterns and growing evidence.</p><p><strong>Methods: </strong>A systematic review of PubMed, Scopus, and Web of Science was undertaken using \"smoking\" and \"prostate cancer.\" The criteria for selecting articles were relevancy, developing research, and accessibility. The exclusion criteria eliminated non-human research and associated issues. This study examined worldwide patterns, however primarily focused on tobacco use and prostate cancer in India according to recent findings. Regional research emphasised smoking and prostate cancer risk patterns and mechanisms.</p><p><strong>Results: </strong>Tobacco use is still a substantial risk factor for several malignancies, including prostate cancer. Globally, smoking has been associated with an increased risk of getting prostate cancer, with research indicating that smokers had a greater prevalence of aggressive illness. Tobacco usage is very common in India owing to a variety of cultural, societal, and economic variables; hence it is a key focus of this research. The effect of tobacco in prostate cancer risk in India is still being studied, and the data shows that smoking in the Indian population may worsen the development and progression of prostate cancer, similar to worldwide patterns but with regional differences.</p><p><strong>Conclusions: </strong>Understanding how smoking affects prostate cancer may improve prevention and early diagnosis, which has public health consequences. These methods may involve targeted screening or lifestyle changes. This review emphasis smoking as a key prostate cancer risk factor, focusing on new Indian findings. More research is required to assess smoking's full impact on prostate cancer risk, particularly in different populations and locations.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"17"},"PeriodicalIF":1.9,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12512299/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145258008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The burden of Alzheimer's disease and related dementias (ADRD) is rising in Africa, yet research remains limited compared to high-income regions. This narrative review investigated the genetic and environmental determinants of ADRD in older African populations, with a focus on the apolipoprotein E (APOE) gene. Although APOE ε4 is a strong risk factor for Alzheimer's disease globally, its role in African populations appears less pronounced and variable, likely due to genetic diversity, evolutionary adaptations, and environmental interactions. We discussed the epidemiology of dementia in Africa, contrasting urban and rural patterns, and examined the distribution and effects of APOE alleles across African regions. Additionally, we reviewed how environmental exposures-including malaria, hypertension, HIV, heavy metals, pesticides, vitamin D deficiency, and air pollution-interact with APOE genotypes to influence cognitive decline. Critical challenges such as healthcare disparities, diagnostic inconsistencies, and underrepresentation in genomic studies were highlighted. Finally, we emphasized the need for longitudinal, multicenter research and initiatives like the African Dementia Consortium to bridge knowledge gaps and inform culturally tailored interventions for dementia prevention and care in Africa.
{"title":"Genetics and environmental determinants of Alzheimer's disease and related dementias in older Africans: a narrative review.","authors":"Tobi Olajide, Oluwatimilehin Oladapo, Chukwuebuka Asogwa, Gideon Olajide, Ayomide Oyekan, Ayomide Fatola, Timileyin Olanrewaju, Damola Oyegbile, Ikechukwu Ugbo, Henry Oyoyo, Ridwan Kamarudeen, Olawale Famakin","doi":"10.1186/s41021-025-00332-0","DOIUrl":"10.1186/s41021-025-00332-0","url":null,"abstract":"<p><p>The burden of Alzheimer's disease and related dementias (ADRD) is rising in Africa, yet research remains limited compared to high-income regions. This narrative review investigated the genetic and environmental determinants of ADRD in older African populations, with a focus on the apolipoprotein E (APOE) gene. Although APOE ε4 is a strong risk factor for Alzheimer's disease globally, its role in African populations appears less pronounced and variable, likely due to genetic diversity, evolutionary adaptations, and environmental interactions. We discussed the epidemiology of dementia in Africa, contrasting urban and rural patterns, and examined the distribution and effects of APOE alleles across African regions. Additionally, we reviewed how environmental exposures-including malaria, hypertension, HIV, heavy metals, pesticides, vitamin D deficiency, and air pollution-interact with APOE genotypes to influence cognitive decline. Critical challenges such as healthcare disparities, diagnostic inconsistencies, and underrepresentation in genomic studies were highlighted. Finally, we emphasized the need for longitudinal, multicenter research and initiatives like the African Dementia Consortium to bridge knowledge gaps and inform culturally tailored interventions for dementia prevention and care in Africa.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"16"},"PeriodicalIF":1.9,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12509407/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145250814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Colibactin is a small genotoxic molecule of polyketide produced by a subset of enteric bacteria including certain Escherichia coli (E. coli) harbored in the human gut microbiota. Its biosynthesis is governed by a multistep enzymatic process encoded by the polyketide synthase (pks) gene cluster. Colibactin is thought to exert its carcinogenic potential primarily through the induction of DNA interstrand crosslinks (ICLs); however, the precise mechanisms underlying its genotoxicity remain largely unresolved. In this study, we focused on ICL formation and its associated repair pathways to investigate whether colibactin-induced ICLs play a central role in the induction of chromosomal aberrations and inhibition of cell proliferation.
Findings: HAP1 cells deficient in FANCD2, a gene essential for ICL repair, and their wild-type counterparts were infected with colibactin producing (clb⁺) E. coli strains isolated from a Japanese colorectal cancer (CRC) patient. Following recovery culture, the frequency of micronucleated (MN) cells was assessed. The results showed that FANCD2-deficient cells exhibited a significantly higher frequency of MN cells compared to wild-type cells. Additionally, the cytotoxicity of the clb⁺ strains was evaluated using the XTT assay. FANCD2-deficient cells demonstrated higher sensitivity to the clb⁺ E. coli strains than wild-type cells.
Conclusion: These findings suggest that colibactin, produced by clb⁺ E. coli, can play a role in the formation of ICLs, thereby contributing significantly to the induction of chromosomal aberrations and the inhibition of human cell proliferation.
大肠杆菌素是一种小的基因毒性聚酮分子,由肠道细菌的一个子集产生,包括人类肠道微生物群中的某些大肠杆菌(E. coli)。它的生物合成是由聚酮合成酶(pks)基因簇编码的多步骤酶促过程控制的。大肠杆菌素被认为主要通过诱导DNA链间交联(ICLs)发挥其致癌潜力;然而,其遗传毒性的确切机制在很大程度上仍未得到解决。在这项研究中,我们关注ICL的形成及其相关的修复途径,以研究大肠杆菌素诱导的ICL是否在诱导染色体畸变和抑制细胞增殖中起核心作用。研究结果:HAP1细胞缺乏FANCD2 (ICL修复所必需的基因),它们的野生型对偶体被从日本结直肠癌(CRC)患者中分离出来的产大肠杆菌蛋白(clb +)大肠杆菌菌株感染。恢复培养后,评估微核(MN)细胞的频率。结果显示,与野生型细胞相比,fancd2缺陷细胞的MN细胞频率明显更高。此外,采用XTT法对clb +菌株的细胞毒性进行了评估。fancd2缺陷细胞对clb +大肠杆菌菌株的敏感性高于野生型细胞。结论:这些发现表明,clb + E. coli产生的大肠杆菌蛋白(colibactin)可以在icl的形成中发挥作用,从而在诱导染色体畸变和抑制人细胞增殖方面发挥重要作用。
{"title":"DNA cross-link repair deficiency enhances human cell sensitivity to colibactin-induced genotoxicity.","authors":"Masanobu Kawanishi, Osamu Tsubohira, Ai Ueshima, Yuuta Hisatomi, Yoshimitsu Oda, Michio Sato, Noriyuki Miyoshi, Michihiro Mutoh, Hideki Ishikawa, Keiji Wakabayashi, Takashi Yagi, Kenji Watanabe","doi":"10.1186/s41021-025-00339-7","DOIUrl":"10.1186/s41021-025-00339-7","url":null,"abstract":"<p><strong>Introduction: </strong>Colibactin is a small genotoxic molecule of polyketide produced by a subset of enteric bacteria including certain Escherichia coli (E. coli) harbored in the human gut microbiota. Its biosynthesis is governed by a multistep enzymatic process encoded by the polyketide synthase (pks) gene cluster. Colibactin is thought to exert its carcinogenic potential primarily through the induction of DNA interstrand crosslinks (ICLs); however, the precise mechanisms underlying its genotoxicity remain largely unresolved. In this study, we focused on ICL formation and its associated repair pathways to investigate whether colibactin-induced ICLs play a central role in the induction of chromosomal aberrations and inhibition of cell proliferation.</p><p><strong>Findings: </strong>HAP1 cells deficient in FANCD2, a gene essential for ICL repair, and their wild-type counterparts were infected with colibactin producing (clb⁺) E. coli strains isolated from a Japanese colorectal cancer (CRC) patient. Following recovery culture, the frequency of micronucleated (MN) cells was assessed. The results showed that FANCD2-deficient cells exhibited a significantly higher frequency of MN cells compared to wild-type cells. Additionally, the cytotoxicity of the clb⁺ strains was evaluated using the XTT assay. FANCD2-deficient cells demonstrated higher sensitivity to the clb⁺ E. coli strains than wild-type cells.</p><p><strong>Conclusion: </strong>These findings suggest that colibactin, produced by clb⁺ E. coli, can play a role in the formation of ICLs, thereby contributing significantly to the induction of chromosomal aberrations and the inhibition of human cell proliferation.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"15"},"PeriodicalIF":1.9,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12451999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145124416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-08-04DOI: 10.1186/s41021-025-00337-9
Esther Ugo Alum, Regina Idu Ejemot-Nwadiaro, Mariam Basajja, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, Patrick Maduabuchi Aja
{"title":"Epitranscriptomic alterations induced by environmental toxins: implications for RNA modifications and disease.","authors":"Esther Ugo Alum, Regina Idu Ejemot-Nwadiaro, Mariam Basajja, Daniel Ejim Uti, Okechukwu Paul-Chima Ugwu, Patrick Maduabuchi Aja","doi":"10.1186/s41021-025-00337-9","DOIUrl":"10.1186/s41021-025-00337-9","url":null,"abstract":"","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"14"},"PeriodicalIF":1.9,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12323242/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144784146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Error-corrected next-generation sequencing (ecNGS) enables the sensitive detection of chemically induced mutations. Matsumura et al. reported Hawk-Seq™, an ecNGS method, demonstrating its utility in clarifying mutagenicity both qualitatively and quantitatively. To further promote the adoption of ecNGS-based assays, it is important to evaluate their inter-laboratory transferability and reproducibility. Therefore, we evaluated the inter-laboratory reproducibility of Hawk-Seq™ and its concordance with the transgenic rodent mutation (TGR) assay.
Results: The Hawk-Seq™ protocol was successfully transferred from the developer's laboratory (lab A) to two additional laboratories (labs B, C). Whole genomic mutations were analyzed independently using the same genomic DNA samples from the livers of gpt delta mice exposed to benzo[a]pyrene (BP), N-ethyl-N-nitrosourea (ENU), and N-methyl-N-nitrosourea (MNU). In all laboratories, clear dose-dependent increases in base substitution (BS) frequencies were observed, specific to each mutagen (e.g. G:C to T:A for BP). Statistically significant increases in overall mutation frequencies (OMFs) were identified at the same doses across all laboratories, suggesting high reproducibility in mutagenicity assessment. The correlation coefficient (r2) of the six types of BS frequencies exceeded 0.97 among the three laboratories for BP- or ENU-exposed samples. Thus, Hawk-Seq™ provides qualitatively and quantitatively reproducible results across laboratories. The OMFs in the Hawk-Seq™ analysis positively correlated (r2 = 0.64) with gpt mutant frequencies (MFs). The fold induction of OMFs in the Hawk-Seq™ analysis of ENU- and MNU-exposed samples was at least 14.2 and 4.5, respectively, compared to 6.1 and 2.5 for gpt MFs. Meanwhile, the fold induction of OMFs in BP-exposed samples was ≤ 4.6, compared to 8.2 for gpt MFs. These observations suggest that Hawk-Seq™ demonstrates good concordance with the transgenic rodent (TGR) gene mutation assay, whereas the induction of mutation frequency by each mutagen might not directly correspond.
Conclusions: Hawk-Seq™-based whole-genome mutagenicity evaluation demonstrated high inter-laboratory reproducibility and concordance with gpt assay results. Our results contribute to the growing evidence that ecNGS assays provide a suitable, or improved, alternative to the TGR assay.
{"title":"Whole genome mutagenicity evaluation using Hawk-Seq™ demonstrates high inter-laboratory reproducibility and concordance with the transgenic rodent gene mutation assay.","authors":"Shoji Matsumura, Sayaka Hosoi, Takako Hirose, Yuki Otsubo, Kazutoshi Saito, Masaaki Miyazawa, Akihiro Kawade, Atsushi Hakura, Dai Kakiuchi, Shoji Asakura, Naoki Koyama, Yuki Okada, Satsuki Chikura, Takafumi Kimoto, Kenichi Masumura, Takayoshi Suzuki, Kei-Ichi Sugiyama","doi":"10.1186/s41021-025-00336-w","DOIUrl":"10.1186/s41021-025-00336-w","url":null,"abstract":"<p><strong>Background: </strong>Error-corrected next-generation sequencing (ecNGS) enables the sensitive detection of chemically induced mutations. Matsumura et al. reported Hawk-Seq™, an ecNGS method, demonstrating its utility in clarifying mutagenicity both qualitatively and quantitatively. To further promote the adoption of ecNGS-based assays, it is important to evaluate their inter-laboratory transferability and reproducibility. Therefore, we evaluated the inter-laboratory reproducibility of Hawk-Seq™ and its concordance with the transgenic rodent mutation (TGR) assay.</p><p><strong>Results: </strong>The Hawk-Seq™ protocol was successfully transferred from the developer's laboratory (lab A) to two additional laboratories (labs B, C). Whole genomic mutations were analyzed independently using the same genomic DNA samples from the livers of gpt delta mice exposed to benzo[a]pyrene (BP), N-ethyl-N-nitrosourea (ENU), and N-methyl-N-nitrosourea (MNU). In all laboratories, clear dose-dependent increases in base substitution (BS) frequencies were observed, specific to each mutagen (e.g. G:C to T:A for BP). Statistically significant increases in overall mutation frequencies (OMFs) were identified at the same doses across all laboratories, suggesting high reproducibility in mutagenicity assessment. The correlation coefficient (r<sup>2</sup>) of the six types of BS frequencies exceeded 0.97 among the three laboratories for BP- or ENU-exposed samples. Thus, Hawk-Seq™ provides qualitatively and quantitatively reproducible results across laboratories. The OMFs in the Hawk-Seq™ analysis positively correlated (r<sup>2</sup> = 0.64) with gpt mutant frequencies (MFs). The fold induction of OMFs in the Hawk-Seq™ analysis of ENU- and MNU-exposed samples was at least 14.2 and 4.5, respectively, compared to 6.1 and 2.5 for gpt MFs. Meanwhile, the fold induction of OMFs in BP-exposed samples was ≤ 4.6, compared to 8.2 for gpt MFs. These observations suggest that Hawk-Seq™ demonstrates good concordance with the transgenic rodent (TGR) gene mutation assay, whereas the induction of mutation frequency by each mutagen might not directly correspond.</p><p><strong>Conclusions: </strong>Hawk-Seq™-based whole-genome mutagenicity evaluation demonstrated high inter-laboratory reproducibility and concordance with gpt assay results. Our results contribute to the growing evidence that ecNGS assays provide a suitable, or improved, alternative to the TGR assay.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"13"},"PeriodicalIF":1.9,"publicationDate":"2025-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12305950/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144741975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Toluene diisocyanates (TDIs) are high-production-volume chemicals widely used in polyurethane manufacturing. A typical commercial-grade TDI (TDI; 2,4-toluene diisocyanate: 2,6-toluene diisocyanate; 80:20), CAS: 26471-62-5, is mutagenic in Salmonella typhimurium with an S9 metabolic activation mix and induces chromosomal aberrations in Chinese hamster lung cells without S9 mix. While oral administration of TDI has been reported to be carcinogenic in female mice and rats of both sexes, its in vivo mutagenicity remains poorly understood. This study aimed to clarify the in vivo mutagenicity of orally administered TDI. In vivo mutagenicity was evaluated following the Organisation for Economic Co-operation and Development Test Guideline 488 (OECD TG488). MutaMouse females were orally dosed with TDI at 0 (corn oil; vehicle control), 250, 500, or 1,000 mg/kg/day for 28 days. Mutant frequencies (MFs) in the liver and glandular stomach were analyzed three days post-final dosing. Positive controls received intraperitoneal injections of N-ethyl-N-nitrosourea (ENU) at 100 mg/kg/day for two days, with MFs assessed ten days after the final dose.
Results: Significant increases in lacZ MFs were observed in the liver at 1,000 mg/kg/day, while MFs in the glandular stomach remained unchanged. Positive controls demonstrated significantly elevated MFs in both the liver and glandular stomach.
Conclusions: These findings indicate that orally administered TDI is mutagenic in mice, supporting its classification as a mutagenic carcinogen.
{"title":"Increased mutagenicity in the liver of MutaMouse females following oral treatment with commercial-grade toluene diisocyanate.","authors":"Mariko Matsumoto, Masakatsu Natsume, Takako Iso, Takaaki Umano, Yasumasa Murata, Kenichi Masumura, Katsuyoshi Horibata, Kei-Ichi Sugiyama","doi":"10.1186/s41021-025-00335-x","DOIUrl":"10.1186/s41021-025-00335-x","url":null,"abstract":"<p><strong>Background: </strong>Toluene diisocyanates (TDIs) are high-production-volume chemicals widely used in polyurethane manufacturing. A typical commercial-grade TDI (TDI; 2,4-toluene diisocyanate: 2,6-toluene diisocyanate; 80:20), CAS: 26471-62-5, is mutagenic in Salmonella typhimurium with an S9 metabolic activation mix and induces chromosomal aberrations in Chinese hamster lung cells without S9 mix. While oral administration of TDI has been reported to be carcinogenic in female mice and rats of both sexes, its in vivo mutagenicity remains poorly understood. This study aimed to clarify the in vivo mutagenicity of orally administered TDI. In vivo mutagenicity was evaluated following the Organisation for Economic Co-operation and Development Test Guideline 488 (OECD TG488). MutaMouse females were orally dosed with TDI at 0 (corn oil; vehicle control), 250, 500, or 1,000 mg/kg/day for 28 days. Mutant frequencies (MFs) in the liver and glandular stomach were analyzed three days post-final dosing. Positive controls received intraperitoneal injections of N-ethyl-N-nitrosourea (ENU) at 100 mg/kg/day for two days, with MFs assessed ten days after the final dose.</p><p><strong>Results: </strong>Significant increases in lacZ MFs were observed in the liver at 1,000 mg/kg/day, while MFs in the glandular stomach remained unchanged. Positive controls demonstrated significantly elevated MFs in both the liver and glandular stomach.</p><p><strong>Conclusions: </strong>These findings indicate that orally administered TDI is mutagenic in mice, supporting its classification as a mutagenic carcinogen.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"12"},"PeriodicalIF":2.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144539982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-26DOI: 10.1186/s41021-025-00334-y
Yusuke Hanaki, Sakae Arimoto-Kobayashi
N-nitrosopyrrolidine (NPYR) is a volatile nitrosamine that is thought to be a human carcinogen. It is found in air, wastewater, food, and feed. Photo-activation of NPYR can occur as it drifts through the environment. We previously found that NPYR irradiated in phosphate buffer was directly mutagenic without metabolic activation or simultaneous irradiation. Here, we aimed to determine NPYR activity after UVA irradiation. The mutagenic activity of irradiated NPYR was relatively stable, and ~ 23% of it persisted after 168 h of storage at 37 °C. Micronuclei (MN) were also found without metabolic activation in human-derived keratinocytes (HaCaT cells) after NPYR irradiation in vitro and the peripheral blood reticulocytes (PBRs) of mice with inhibited cytochrome-P450-mediated metabolism then injected with irradiated NPYR in vivo. The active photoproduct of NPYR is thought to be genotoxic to bone marrow, resulting in MN formation in PBRs. The action spectrum of MN formation in PBRs exposed to NPYR irradiated with monochromatic light was plotted along the absorption curve. The production ratio of active NPYR photoproduct followed the NPYR absorption curve. Genotoxicity becomes systemic with externally irradiated NPYR that penetrates the skin or when NPYR is irradiated just under the skin and enters the systemic circulation. Risk analyses of public health-related volatile N-nitrosamines generated via environmental photoactivation including NPYR, should be considered.
n -亚硝基吡咯烷(NPYR)是一种挥发性亚硝胺,被认为是人类致癌物。它存在于空气、废水、食物和饲料中。当NPYR在环境中漂移时,会发生光活化。我们之前发现NPYR在磷酸盐缓冲液中辐照后直接致突变,没有代谢激活或同时辐照。在这里,我们的目的是测定UVA照射后NPYR的活性。辐照后NPYR的诱变活性相对稳定,37℃保存168 h后仍有23%的诱变活性存在。在体外NPYR照射后,人源性角质形成细胞(HaCaT细胞)中也发现微核(MN)没有代谢激活,在体内注射NPYR后,细胞色素p450介导的代谢受到抑制的小鼠外周血网状细胞(PBRs)中也发现微核(MN)。NPYR的活性光产物被认为对骨髓具有遗传毒性,导致pbr中MN的形成。沿着吸收曲线绘制了单色光照射NPYR后pbr中MN形成的作用谱。活性NPYR光产物的产率符合NPYR吸收曲线。外源照射的NPYR穿透皮肤或NPYR仅在皮肤下照射并进入体循环时,遗传毒性变为全身性。应考虑通过包括NPYR在内的环境光活化产生的与公共健康有关的挥发性n -亚硝胺的风险分析。
{"title":"In vivo and in vitro genotoxicity of N-nitrosopyrrolidine following UVA irradiation.","authors":"Yusuke Hanaki, Sakae Arimoto-Kobayashi","doi":"10.1186/s41021-025-00334-y","DOIUrl":"10.1186/s41021-025-00334-y","url":null,"abstract":"<p><p>N-nitrosopyrrolidine (NPYR) is a volatile nitrosamine that is thought to be a human carcinogen. It is found in air, wastewater, food, and feed. Photo-activation of NPYR can occur as it drifts through the environment. We previously found that NPYR irradiated in phosphate buffer was directly mutagenic without metabolic activation or simultaneous irradiation. Here, we aimed to determine NPYR activity after UVA irradiation. The mutagenic activity of irradiated NPYR was relatively stable, and ~ 23% of it persisted after 168 h of storage at 37 °C. Micronuclei (MN) were also found without metabolic activation in human-derived keratinocytes (HaCaT cells) after NPYR irradiation in vitro and the peripheral blood reticulocytes (PBRs) of mice with inhibited cytochrome-P450-mediated metabolism then injected with irradiated NPYR in vivo. The active photoproduct of NPYR is thought to be genotoxic to bone marrow, resulting in MN formation in PBRs. The action spectrum of MN formation in PBRs exposed to NPYR irradiated with monochromatic light was plotted along the absorption curve. The production ratio of active NPYR photoproduct followed the NPYR absorption curve. Genotoxicity becomes systemic with externally irradiated NPYR that penetrates the skin or when NPYR is irradiated just under the skin and enters the systemic circulation. Risk analyses of public health-related volatile N-nitrosamines generated via environmental photoactivation including NPYR, should be considered.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"11"},"PeriodicalIF":2.7,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12105390/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144150269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-05-21DOI: 10.1186/s41021-025-00333-z
Takashi Yagi
This article outlines the history and development of Genes and Environment, the official journal of the Japanese Environmental Mutagen and Genome Society (JEMS). In the 1970s, there was growing concern about the mutagenicity of chemical substances, leading to the establishment of JEMS. The society began publishing its journal, Environmental Mutagen Research, and renamed Genes and Environment in 2006 to focus on gene-environment interactions and promote international collaboration. The journal transitioned to free-access and started publishing in English to expand its reach globally.From 2012, the journal partnered with BioMed Central (BMC) to become an open-access publication, leading to its inclusion in Scopus, PubMed, and SCIE, and an improvement in its CiteScore and Impact Factor. JEMS also sought funding from Japan's Grants-in-Aid for Scientific Research (KAKENHI) to support international dissemination of research.Despite progress, challenges remain, such as limited submissions from certain regions and a need for greater global recognition. To further internationalize JEMS, efforts are being made to elevate the quality of research and broaden membership diversity, with a focus on making JEMS' activities and publications more accessible to the global scientific community.
{"title":"Genes and Environment: reflections on its journey, past and future.","authors":"Takashi Yagi","doi":"10.1186/s41021-025-00333-z","DOIUrl":"10.1186/s41021-025-00333-z","url":null,"abstract":"<p><p>This article outlines the history and development of Genes and Environment, the official journal of the Japanese Environmental Mutagen and Genome Society (JEMS). In the 1970s, there was growing concern about the mutagenicity of chemical substances, leading to the establishment of JEMS. The society began publishing its journal, Environmental Mutagen Research, and renamed Genes and Environment in 2006 to focus on gene-environment interactions and promote international collaboration. The journal transitioned to free-access and started publishing in English to expand its reach globally.From 2012, the journal partnered with BioMed Central (BMC) to become an open-access publication, leading to its inclusion in Scopus, PubMed, and SCIE, and an improvement in its CiteScore and Impact Factor. JEMS also sought funding from Japan's Grants-in-Aid for Scientific Research (KAKENHI) to support international dissemination of research.Despite progress, challenges remain, such as limited submissions from certain regions and a need for greater global recognition. To further internationalize JEMS, efforts are being made to elevate the quality of research and broaden membership diversity, with a focus on making JEMS' activities and publications more accessible to the global scientific community.</p>","PeriodicalId":12709,"journal":{"name":"Genes and Environment","volume":"47 1","pages":"10"},"PeriodicalIF":1.9,"publicationDate":"2025-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093807/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}